CALCCALCIMEDICACALC info
$3.92info1.29%24h
Global rank29523
Market cap$22.28M
Change 7d-1.26%
YTD Performance33.33%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    CALCIMEDICA (CALC) Stock Overview

    CalciMedica, Inc., a clinical-stage biotechnology company, focuses on developing therapies for life-threatening inflammatory diseases with unmet needs. Its proprietary technology targets the inhibition of calcium release-activated (CRAC) channels designs to modulate the immune response and protect against tissue cell injury in life-threatening inflammatory diseases. Its lead product candidate is Auxora, a proprietary intravenous-formulated CRAC channel inhibitor for the treatment of acute pancreatitis, asparaginase-associated acute pancreatitis, and acute kidney injury. The company is based in La Jolla, California.

    CALC Stock Information

    Symbol
    CALC
    Address
    505 Coast Boulevard SouthLa Jolla, CA 92037United States
    Founded
    -
    Trading hours
    -
    Website
    https://www.calcimedica.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    858-952-5500

    CALCIMEDICA (CALC) Price Chart

    -
    Value:-

    CALCIMEDICA Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $3.92
    N/A
    Market Cap
    $22.28M
    N/A
    Shares Outstanding
    5.68M
    N/A
    Employees
    14.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org